CGNSF Stock Price, Chart, Stats & News

Cognetivity Neurosciences Ltd.
Save
Cognetivity Neurosciences Ltd. (CGNSF) does not currently pay a dividend.
8,959
Market cap
–
Current P/E
35.09x
Forward P/E
CGNSF chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Medical - Healthcare Information Services
Industry
Cognetivity Neurosciences Ltd. is a healthcare firm focused on advanced cognitive assessment. The company has developed a sophisticated platform for cognitive testing, designed for use across diverse settings including medical facilities, commercial environments, and by individual consumers. This innovative system's primary goal is to identify the very first signs of cognitive impairment through a comprehensive evaluation of broad brain functions, thereby assisting in the diagnosis of conditions like dementia.
Similar securities
Based on sector and market capitalization
Report issue





